STEM. Is it too early? or just the right time.

103
Trade idea. Choppy. Pay close attention to RSI and MAC D histo. Price targets in blue upon validation.

First Half 2014: Initiate Phase II efficacy trial in spinal cord treatment

2014: Initiate Phase II efficacy trial in AMD

2015: Interim results of proof of concept trials on both AMD and spinal cord injuries

2016: The company plans to file an IND for the safety and efficacy of HuCNS-SC cells to restore memory loss in Alzheimer's patients.

면책사항

이 정보와 게시물은 TradingView에서 제공하거나 보증하는 금융, 투자, 거래 또는 기타 유형의 조언이나 권고 사항을 의미하거나 구성하지 않습니다. 자세한 내용은 이용 약관을 참고하세요.